Clinical Trials Browser

Phase 2 × Terminated × Interleukin 1 Receptor Antagonist Protein × Clear all

NCT04205838 2026-02-27

Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma

Phase 2 Terminated

Lymphoma, Large B-Cell, Diffuse, Disease Progression

NCT00537667 2009-11-26

The SPECTRA Study

Phase 2 Terminated

Arthritis, Rheumatoid, Inflammation